Patent details

EP0868911 Title: Rapamycin formulations for oral administration

Basic Information

Publication number:
EP0868911
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP983017161
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Rapamycin formulations for oral administration
French Title of Invention:
Formulations de rapamycine pour administration orale
German Title of Invention:
Rapamycin enthaltende Formulierungen zur oralen Verabreichung
SPC Number:

Dates

Filing date:
09/03/1998
Grant date:
11/09/2002
EP Publication Date:
11/09/2002
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/10/1998
EP B1 Publication Date:
11/09/2002
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/03/2018
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/03/1998
 
 

Name:
Wyeth
Address:
Five Giralda Farms, Madison, New Jersey 07940-0874, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
11/09/2002
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Nagi Arwinder S.
Address:
United States (US)

Priority

Priority Number:
815015
Priority Date:
14/03/1997
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/28;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
07/03/2017
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages